Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

समान संसाधन

• Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer
  द्वारा: Bardelli, Alberto, और अन्य
  प्रकाशित: (2013)
• Monitoring clonal evolution and resistance to EGFR blockade in the blood of metastatic colorectal cancer patients
  द्वारा: Siravegna, Giulia, और अन्य
  प्रकाशित: (2015)
• Emergence of KRAS mutations and acquired resistance to anti EGFR therapy in colorectal cancer
  द्वारा: Misale, Sandra, और अन्य
  प्रकाशित: (2012)
• Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis
  द्वारा: Pizzutilo, Elio Gregory, और अन्य
  प्रकाशित: (2021)
• NTRK gene fusions as novel targets of cancer therapy across multiple tumour types
  द्वारा: Amatu, Alessio, और अन्य
  प्रकाशित: (2016)